to explore results)
- Successful Strategies for the Discovery of Antiviral Drugs, CHAPTER 13 Cobicistat and Ritonavir as Pharmacoenhancers for Antiviral Drugs.
, Pages 451-481
- Biocatalysis: An Industrial Perspective, CHAPTER 5 Bristol-Myers Squibb: Preparation of Chiral Intermediates for the Development of Drugs and APIs.
, Pages 125-167
- Conference on Drug Design and Discovery Technologies, Enhancement of Atazanavir Solubility Using β-Cyclodextrin Based Nanosponges.
, Pages 207-211
- Biocatalysis: An Industrial Perspective, Contents
, Pages P009-P020
- Metabolism, Pharmacokinetics and Toxicity of Functional Groups: Impact of Chemical Building Blocks on ADMET, Chapter 9 Pharmacokinetics and Metabolism of Compounds that Mimic Enzyme Transition States.
, Pages 390-459
- Drug Design Strategies: Quantitative Approaches, Chapter 5 Contribution of Structure-Based Drug Design to the Discovery of Marketed drugs.
, Pages 108-163
- New Horizons in Predictive Drug Metabolism and Pharmacokinetics, CHAPTER 5 Non-Cytochrome P450 Enzymes and Glucuronidation.
, Pages 79-130
- Drug Transporters: Volume 2: Recent Advances and Emerging Technologies, Chapter 5 Pharmacogenomics of Drug Transporters: Clinical Implications.
, Volume 2
, Pages 114-142
- Pharmaceutical Process Development: Current Chemical and Engineering Challenges, Chapter 1 Introduction.
, Pages 1-14
- Metabolism, Pharmacokinetics and Toxicity of Functional Groups: Impact of Chemical Building Blocks on ADMET, Chapter 11 Future Targets and Chemistry and ADME Needs.
, Pages 486-511